Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Samsung Electronics
- License Information
-
More Information
Article History
Received: 10 July 2026
Accepted: 25 August 2026
First Online: 1 September 2026
Declarations
Ethics approval and consent to participate: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of CHA University Medical Center (IRB approval number: CHAMC 1044308-202503-BR-237-02). Written informed consent was obtained from all participants before participation.
Consent for publication: Not applicable.
Patient and public involvement: Patients or the public were not involved in the design, conduct, reporting, or dissemination plans of this study.
Competing interests: This study was funded by Samsung Electronics, the manufacturer of the Bot-Fit device evaluated in this study. Samsung Electronics had no role in the study design, data collection, data analysis, interpretation of the results, manuscript preparation, or the decision to submit the manuscript for publication. The authors declare no other competing interests.
